Mobile-health Network Solutions Reported Wednesday It Will Offer GLP-1 Injectables for Medical Weight Loss From $10/Day
Mobile-health Network Solutions Reported Wednesday It Will Offer GLP-1 Injectables for Medical Weight Loss From $10/Day
移動醫療網絡解決方案週三報道稱，將提供每天10美元的GLP-1注射劑醫療減肥服務。
Mobile-health Network Solutions ['MaNaDr'](NASDAQ:MNDR), a leading Asia-Pacific telehealth provider, today announced updated pricing for its medical weight management program, improving the affordability and accessibility of GLP-1 (glucagon-like peptide-1) receptor agonist medications?in the Asia-Pacific (APAC) region.
亞太地區領先的遠程醫療服務提供商MaNaDr（納斯達克股票代碼：MNDR）今天宣佈，更新了其醫療減重計劃的定價，改善了亞太地區GLP-1（類GLP-1受體激動劑）受體激動劑藥物的可負擔性和可訪問性。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。